JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
View Older Stories
-
Notable Analyst Rating Changes 08/24: (ELN) (TSO) (SKS) Upgraded; (BSX) (X) (UTHR) Downgraded
-
Paulson & Co. Slashes Stake in BofA (BAC), Citigroup (C); Shows New Stakes in Mosaic (MOS) and News Corp (NWSA)
-
Cooperman's Omega Advisors Shows Lower Tech Exposure, Raises Bet on Consumer Electronic Sales
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Paulson's Paulson & Co Shows New Stakes In Alpha Natural (ANR), Family Dollar (FDO), HP (HP); Raises Transocean (RIG) and Liquidates Pfizer (PFE)
-
Paulson's Paulson & Co. Reduces Citi (C) Exposure; Keeps Gold Level; Likes Tech (STX)(RIG)ABX)(JPM)
-
Top 10 News Items 1/31-2/4: Jobs Report Adversely Impacted by Severe Winter Weather, Stocks Shrug at Unrest in Egypt, Q4 Earnings Season Winding Down
-
Daily State of the Markets 02/03: Nobody Home?
-
JPMorgan Names 2011's Best, Worst Picks for MedTech Sector (STJ, COV, PODD, BMTI, more)
-
UPDATE - J.P. Morgan Lowers Boston Scientific to Underweight; BSX Has Lack of Growth in Portfolio
-
JPMorgan Downgrades Boston Scientific (BSX) to Underweight
-
Paulson's Paulson & Co. Keeps Gold Rush Alive, Moves Out of Goldman and Increases Citi Stake (C, GS, ABX, APC, XOM, More...)
-
Daily State of the Markets: Seeing What They Want to See?
-
Soros' Moves Lower in Telecom, Major Retailers; Becomes Bullish on the U.S. Dollar (T, S, UUP, WMT, SIRI, More...)
-
John Paulson Shows New Stakes In Exxon Mobil (XOM) and Goldman Sachs (GS), Raises Pfizer (PFE) Stake
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
Notable Mergers and Acquisitions of the Day 04/16: ORCL/PFWD, CEG, MEDQ
-
Unusual 11 Mid-Day Movers 3/15: PABK, CHRD, SINO, CIGX, CXG Higher; GKK, BOFL, BSX, STRL Lower
-
Notable Analyst Rating Changes 03/15: WMT, RAX, LGF, SIRO Upgraded; BSX, ACI, HCP, ICE, SLE, ARMH, AKAM Downgraded
-
Morning Movers 3/15: CHRD, ALKS, AMLN, PVH Higher; FIGI, MNKD, BSX, JST Lower
-
J.P. Morgan Downgrades Boston Scientific (BSX) to Neutral
-
John Paulson's Paulson & Co Q4 13F Breakdown: Greatly Expands Positions in Banks, Remains Heavy In Gold
-
Analyst Round-Up Boston Scientific (BSX): 3 Downgrades, 7 Price Target Cuts Since Q4 Earnings
-
Notable Analyst Rating Changes for 02/12: MAR, RIMM, CBS, DHI Upgraded; CML, CSTR, NILE, BSX Downgraded
-
Notable Analyst Rating Changes of the Day 02/11: SOL, PALM, CPA, NVDA, ENER, HUBG Upgraded; SNI, FE, DF, BSX Downgraded
-
David Moenning's Daily State of the Markets: 7/21
-
Gabelli Upgrades Boston Scientific (BSX) to Buy
-
David Moenning’s Daily State of the Markets: 6/26
-
John Pauslon Gets Very Long Gold, Also Likes Big Phama (GLD, GDX, WYE, SGP)
-
David Moenning's Daily State of the Markets: 4/21
-
Notable Analyst Rating Changes 1/30: TER, TRA, AZN, BSX Upgraded; X, ALL, SGP, UA Downgraded
-
David Moenning's Daily State of the Markets: 1/29
-
Notable Analyst Rating Changes 11/20: DSX, BIDU, ATR Upgraded; EGLE, SOL, AMED, PAY Downgraded
-
David Moenning's Daily State of the Markets: 10/22
-
Notable Analyst Rating Changes 9/5: UL, MON, NAV, HOS Upgraded; ANF, TJX, AMD, NBR Downgraded
-
Notable Analyst Rating Changes 7/25: DAL, GOOG, CSIQ, JNPR Upgraded; SIRI, SSP, ANF Downgraded
-
David Moenning's Daily State of the Markets: 4/22
-
David Moenning's Daily State of the Markets: 2/5
-
David Moenning's Daily State of the Markets: 1/17
-
David Moenning's Daily State of the Markets: 1/16
